These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1573303)

  • 1. Time lag between case registration and commencement of treatment in a leprosy control unit.
    Murthy PK; Subramanian M; Reddy BN; Rao PS; Neelan PN
    Indian J Lepr; 1992; 64(1):8-13. PubMed ID: 1573303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
    Pandey A; Uddin MJ; Patel R
    Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in leprosy over fifty years in Gudiyatham Taluk, Vellore, Tamil Nadu.
    Norman G; Raja Samuel Bhushanam JD; Samuel P
    Indian J Lepr; 2006; 78(2):167-85. PubMed ID: 16927851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on trend of relapse in leprosy and factors influencing relapse.
    Ali MK; Thorat DM; Subramanian M; Parthasarathy G; Selvaraj U; Prabhakar V
    Indian J Lepr; 2005; 77(2):105-15. PubMed ID: 16044808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of uniform-MDT and WHO MDT in Pauci and Multi bacillary leprosy patients over 24 months of observation.
    Rao PN; Suneetha S; Pratap DV
    Lepr Rev; 2009 Jun; 80(2):143-55. PubMed ID: 19743618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological trends of leprosy elimination in CLTRI rural field operation area, Tamil Nadu, India.
    Subramanian M; Thorat DM; Krishnan CB; Baig AA; Prabakaran I; Hassan TF; Oommen PK
    Indian J Lepr; 2006; 78(2):203-14. PubMed ID: 16927854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of relapse after MDT in a district in West Bengal, India.
    Haldar A; Mahapatra BS; Mundle M; Haldar S; Saha AK
    Indian J Lepr; 2003; 75(1):1-8. PubMed ID: 15253389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in detection of new leprosy cases at two centres in Himachal Pradesh, India: a ten-year study.
    Mahajan VK; Sharma NL; Rana P; Sood N
    Indian J Lepr; 2003; 75(1):17-24. PubMed ID: 15253391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A descriptive study of MDT services in Chhattisgarh.
    Pandey A
    Indian J Lepr; 2008; 80(1):11-7. PubMed ID: 19295117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug therapy in leprosy can prevent relapse--a retrospective study.
    Biswas S; Mondal KK
    Indian J Lepr; 2002; 74(4):313-8. PubMed ID: 12624979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives of leprosy patients on MDT services after integration of NLEP functions into primary health care.
    Sahu T; Sahani NC; Sahu SK
    Indian J Lepr; 2003; 75(3):225-31. PubMed ID: 15267192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up.
    Richardus JH; Nicholls PG; Croft RP; Withington SG; Smith WC
    Int J Epidemiol; 2004 Apr; 33(2):337-43. PubMed ID: 15082636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in new case-detection leprosy in Bihar, India.
    Vijayakumaran P; Prasad B; Krishnamurthy P
    Indian J Lepr; 2006; 78(2):145-51. PubMed ID: 16927849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing epidemiological pattern of leprosy in rural Chhattisgarh.
    Pandey A; Uddin MJ; Patel R
    Indian J Lepr; 2005; 77(1):26-37. PubMed ID: 16173417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of MDT on incidence rates of leprosy among household contacts. Part 1. Baseline data.
    Sundar Rao PS; Jesudasan K; Mani K; Christian M
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):647-51. PubMed ID: 2778370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
    Kamal R; Dayal R; Katoch VM; Katoch K
    Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on the impact of FD-MDT on 200 leprosy patients.
    Vara N; Marfatiya Y
    Indian J Lepr; 2005; 77(3):217-27. PubMed ID: 16353520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delay in presentation, an indicator for nerve function status at registration and for treatment outcome--the experience of the Bangladesh Acute Nerve Damage Study cohort.
    Nicholls PG; Croft RP; Richardus JH; Withington SG; Smith WC
    Lepr Rev; 2003 Dec; 74(4):349-56. PubMed ID: 14750580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on non-adherence to MDT among leprosy patients.
    Rao PS
    Indian J Lepr; 2008; 80(2):149-54. PubMed ID: 19425509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.